First Global Credit Stock News Roundup – 1st October

Share:

The latest news round up for trade-able items on the First Global Credit platform, covering:

Amazon.com

Biogen Idec

Bitcoin

Boeing Co

Eli Lilly & Co

Gold

Tesla Motors

Twitter

Amazon.com, Inc (NASDAQ:AMZN)

Amazon.com’s stock had its “buy” rating reaffirmed by research analysts at Oppenheimer in a report released on Wednesday.

In other Amazon.com news, SVP Diego Piacentini sold 17,016 shares of the stock in a transaction on Monday, August 17th. The shares were sold at an average price of $529.76, for a total value of $9,014,396.16. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Patricia Q. Stonesifer sold 6,250 shares of the stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $505.13, for a total transaction of $3,157,062.50. Following the completion of the sale, the director now owns 32,803 shares in the company, valued at $16,569,779.39.

Shares of Amazon.com traded up 3.19% during trading on Wednesday, reaching $511.89. The company had a trading volume of 3,995,381 shares. The firm’s market capitalization is $239.42 billion. Amazon.com has a 12 month low of $284.00 and a 12 month high of $580.57. The firm’s 50 day moving average price is $518.17 and its 200 day moving average price is $454.05.

The most aggressive covering Wall Street analyst according to Zack’s Research has a short-term target price of $494 on Biogen Idec Inc. (NASDAQ:BIIB) shares. When taking into account all of the research brokage firms polled by Zacks, the consensus price target sits at $398.647. This is based on the 17 providing one-year targets on the shares. On the contrary, the most bearish, or conservative analyst has a one year target of $316.

Zacks uses an average brokerage recommendation (ABR) rating system in order to provide a simplified scale for understanding the calculated average of the actual Buy, Sell, Hold ratings made by research analysts. A stock is given a rating between 1 and 5 where 1 represents a Strong Buy and 5 a Strong Sell. Biogen Idec Inc. (NASDAQ:BIIB) shares currently have a Zacks ABR of 1.8 .

One of the most important indicators for future stock movement is a company’s earnings. Most recently, Biogen Idec Inc. (NASDAQ:BIIB) reported earnings per share of $3.93 for the fiscal quarter ended on 2015-06-30. This resulted in a surprise factor of 3.69%, or $0.15 away from the latest Zacks consensus estimates just prior to the earnings announcement.

For the current quarter, analysts are anticipating earnings around $3.93 per share. This is the current consensus number based on the 17 analysts taken into consideration by Zacks.

1. Nobody controls bitcoin.
Not one person, not one organisation and not one country. It is a thing. And it is open for anyone to use it, yet nobody can change it, or alter it. It is fully distributed, via its public ledger and this is very unique to bitcoin. It’s also anonymous.

2. There will never be more than 21 million bitcoins.
This creates a level of scarcity and value protection that no other currency has had before. Even gold. (Gold has had a 2% extraction rate per year on average). To have enough currency, we simply divide by another decimal point.

3. Bitcoins can be sent to anybody, in the world, in real-time and for free.
Up until now, this has been impossible. All forms of currency exchange up until now always needed physical transport or to trust some third party, such as a clearing house, a credit operation, a settlement house or a bank, who also skim margin. They are all inefficient and relatively expensive. Bitcoin is peer-to-peer.

For more go to: http://www.startupsmart.com.au/growth/three-reasons-the-global-adoption-of-bitcoin-is-inevitable/2015100115625.html

Boeing Co (NYSE:BA)

Investors sold shares of Boeing (NYSE:BA) on strength during trading hours on Tuesday. $88.64 million flowed into the stock on the tick-up and $116.30 million flowed out of the stock on the tick-down, for a money net flow of $27.66 million out of the stock. Boeing traded up $0.62 for the day and closed at $128.75.

A number of equities research analysts have recently weighed in on BA shares. Cowen and Company reiterated an “outperform” rating and issued a $175.00 price objective on shares of Boeing in a report on Monday, June 8th. Zacks upgraded shares of Boeing from a “hold” rating to a “buy” rating and set a $163.00 price target for the company in a report on Tuesday, June 23rd. Sterne Agee CRT reiterated a “buy” rating and issued a $196.00 price objective on shares of Boeing in a research note on Wednesday, June 24th. Deutsche Bank reissued a “buy” rating and issued a $175.00 price target on shares of Boeing in a research report on Thursday, July 2nd. Finally, JPMorgan Chase & Co. initiated coverage on shares of Boeing in a report on Tuesday, July 14th. They set an “overweight” rating and a $175.00 price objective on the stock. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, sixteen have assigned a buy rating and one has issued a strong buy rating to the stock.

The stock currently has a consensus rating of “Buy” and an average price target of $165.95.

A notable mover in September 30th trading session was Eli Lilly and Company as the stock opened the most recent session at 81.53 and at the time of writing the last Bid was at 83.11. In the current trading session the stock reached as high as 83.34 and dipped down to 81.50. Eli Lilly and Company Common St, a NYQ listed company, has a current market cap of 88.24B and on average over the past 3 months has seen 5092910 shares trade hands on a daily basis.

There are a number of sell-side research firms which offer projections on earnings and future direction of the stock. Wall Street analysts have a consensus short term price of 96.50 on the equity. On a trailing twelve month basis, the company’s earnings per share stands at 1.93. The consensus analyst estimates according to Thomson Reuters First Call for the next quarter is 0.78. The current year EPS estimate on the stock is 3.28 and the EPS estimate for next year sits at 3.60.

On a technical level the stock has a 50 Day Moving Average of 83.30. Based on a recent trade, this puts the equity at -0.22% away from that average. In comparing the stock’s current level to its extended history, the stock is trading -10.49% away from its 52-week high of 92.85 and +37.19% away from the stock’s low point over the past 52 weeks, which was 60.58.

Gold fell for a fifth day ahead of the U.S. payrolls report on Friday, which could bolster the case for an interest-rate rise after private jobs data showed an increase in hiring. Platinum and palladium gained.

Bullion for immediate delivery lost 0.2 percent to $1,112.63 an ounce at 2:56 p.m. in Singapore. Prices touched a two-week low of $1,111.83 on Wednesday, according to Bloomberg generic pricing.

Gold has fallen for five straight quarters as the U.S. prepares to raise borrowing costs amid an improving economy, denting the metal’s appeal because it doesn’t pay interest. U.S. companies stepped up hiring in September, indicating the jobs market is standing firm in the face of weaker global demand, figures from the ADP Research Institute showed Wednesday. Labor Department data on Friday are projected to show payroll gains accelerated last month compared with August.

“Gold prices came under pressure with upbeat U.S. economic data,” Australia & New Zealand Banking Group Ltd. said in a note Thursday. “ADP data shows U.S. payrolls in September could beat forecast estimates.”

Tesla Motors‘s stock had its “buy” rating reaffirmed by research analysts at Stifel Nicolaus in a research report issued to clients and investors on Thursday, ARN reports. They currently have a $400.00 price objective on the electric vehicle producer’s stock. Stifel Nicolaus’ price target indicates a potential upside of 61.03% from the stock’s current price.

In other Tesla Motors news, VP Jerome M. Guillen sold 1,500 shares of the firm’s stock in a transaction that occurred on Wednesday, July 15th. The shares were sold at an average price of $264.53, for a total transaction of $396,795.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Elon Musk acquired 82,645 shares of the business’s stock in a transaction on Wednesday, August 19th. The shares were bought at an average price of $242.00 per share, with a total value of $20,000,090.00. The disclosure for this purchase can be found here.

Tesla Motors (NASDAQ:TSLA) opened at 248.40 on Thursday. The stock’s market capitalization is $31.58 billion. The stock has a 50 day moving average price of $248.09 and a 200-day moving average price of $241.65. Tesla Motors has a 12-month low of $181.40 and a 12-month high of $286.65.

Twitter Inc stock is up by as much as 4% today after a report published on Re/Code earlier suggests that interim CEO Jack Dorsey will carry on in this role in the company, on a permanent basis. According to the report, Twitter will officially announce Mr. Dorsey as the company’s permanent CEO. At the same time, however, the report notes that there is a slight chance of delay in the official announcement according to certain unnamed sources, close to the matter.

Jack Dorsey will also lead his other venture; Square, simultaneously. Investors have waited long for Twitter to fill in the leadership vacuum left by Dick Costello, back in June. The uncertainty around Twitter’s leadership has taken a serious toll on its stock, in the past few months. Over the last 12 months, shares of the company are down by nearly 30% and in several instances have traded below the company’s IPO price of $26. The stock still flirts with similar price levels with the latest close reported at $26.46. Several investment firms have raised concerns that the company should be quick in its search for a chief executive to sustain investor confidence.

Trading cryptocurrency, currency, equities and ETFs is potentially risky. You should proceed with caution before trading on the site. By using the Panxora website and/or platforms, you represent that you understand the risk associated with trading cryptocurrencies and global markets. Panxora trades global securities, including US stocks. The company does not have a presence in the United States and are not a US Regulated Broker Dealer. We currently do not accept traders residing in the United States of America. Traders residing within the EU are not permitted to trade stock or ETF products.